GENE ONLINE|News &
Opinion
Blog

Dupixent
Sanofi Appoints New CEO Following Paul Hudson Departure Amid R&D Setbacks
2026-02-13
Dupixent Makes History with FDA Approval as First New CSU Treatment in Over a Decade
2025-04-20
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
Asthma Medications: From Quick Relief to Long-Term Control
2024-03-11
Sanofi and Regeneron’s Dupixent Snags its Tenth Approval From the FDA
2022-09-29
Sanofi and Regeneron Post Positive Results from Child Throat Disease Trial
2022-07-15
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
Regeneron & Sanofi’s Phase 3 Dupixent Data on Children Under Regulatory Review
2020-04-10
Pfizer’s Dupixent Rival Meets Endpoints in Atopic Dermatitis Trial
2020-04-05
GSK Reports Positive Results for Nucala in Patients with Nasal Polyps
2020-04-05
LATEST
Health Insurers Adopt Wearable Data Tracking Models Similar to Automotive Telematics
2026-08-14
Biogen’s Alzheimer’s Tau Drug Splits Experts: Can Diranersen Challenge Leqembi?
2026-08-14
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
La Mojana Earthworks Reveal Long-Term Sustainable Water Management by Pre-Hispanic Societies
2026-08-13
Grant Evaluators Divided Over Prioritizing Past Performance Versus Future Potential
2026-08-13
UC Riverside Study Finds High-Intensity Running Does Not Reduce Lifespan in Mice
2026-08-13
Scroll to Top